How are they going to do a head-to-head trial with Tasigna et al without 50/50 or 100% of funding from a partner? There is NO WAY this financing gets them through their current Phase 2/3 trial in CML and other cancers ***AND*** a massive front-line comparator trial. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=55946698
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.